연구동향 분석

Assessment of Therapeutic Drug Monitoring of Vancomycin in Elderly Patients According to New Guidelines

오세진 홍기숙 이은정 최희정 공경애 이미애 정화순 2014년

논문상세정보
인용/피인용
' Assessment of Therapeutic Drug Monitoring of Vancomycin in Elderly Patients According to New Guidelines' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • therapeuticdrugmonitoring
  • troughconcentration
  • vancomycin
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,626 0

0.0%

' Assessment of Therapeutic Drug Monitoring of Vancomycin in Elderly Patients According to New Guidelines' 의 참고문헌

  • 한국인에서 Vancomycin의 치료적 약물농도 평가
    송영구 Infection and Chemotherapy 36 5 311-318 [2004]
  • Vancomycin: a 50-yr reassessment
    Moellering RC Jr Clin Infect Dis 42 1 3-4 [2006]
  • Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire
    Tobin CM J Antimicrob Chemother 50 713-718 [2002]
  • Vancomycin revisited: a reappraisal of clinical use
    Cunha BA Crit Care Clin 24 393-420 [2008]
  • Vancomycin dosing for pneumonia in critically ill trauma patients
    Patanwala AE J Trauma 67 802-804 [2009]
  • Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility
    Howden BP Clin Infect Dis 38 521-528 [2004]
  • Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
    Rybak M Am J Health Syst Pharm 66 82-98 [2009]
  • Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
    김대일 Korean Journal of Pediatrics 53 12 1000-1005 [2010]
  • Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients
    del Mar Fernández Intensive Care Med 33 279-285 [2007]
  • Pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring of glycopeptides
    MacGowan AP Ther Drug Monit 20 473-477 [1998]
  • Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
    Moise-Broder PA Clin Pharmacokinet 43 925-942 [2004]
  • Limitations of vancomycin in the management of resistant staphylococcal infections
    Kollef MH Clin Infect Dis 45 3 191-195 [2007]
  • High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures
    Pea F J Anti microb Chemother 45 329-335 [2000]
  • Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
    American Thoracic Society; Infectious Diseases Society of America Am J Respir Crit Care Med 171 388-416 [2005]
  • Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index
    Verhave JC Am J Kidney Dis 46 233-241 [2005]
  • Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia
    Sakoulas G J Antimicrob Chemother 57 699-704 [2006]
  • British National Formulary
  • Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients
    Eiland LS Ann Pharmacother 45 582-589 [2011]